1. Genetics Institute, Inc. (31 from 389 patents)

2. Glycosyn LLC (20 from 20 patents)

3. Biogen Idec Ma Inc. (5 from 216 patents)

4. The General Hospital Corporation (3 from 2,893 patents)

5. The Trustees of Boston College (2 from 111 patents)

6. Other (1 from 832,843 patents)

7. Ono Pharmaceutical Co., Ltd. (1 from 575 patents)

8. Biogen Ma Inc. (1 from 250 patents)

1. 11643675 - Alpha (1,2) fucosyltransferase syngenes for use in the production of fucosylated oligosaccharides

2. 11618912 - Microorganisms and methods for producing sialylated and n-acetylglucosamine-containing oligosaccharides

3. 11453900 - Alpha (1,3) fucosyltransferases for use in the production of fucosylated oligosaccharides

4. 11331329 - Fucosylated oligosaccharides for prevention of coronavirus infection

5. 11324766 - 2'-fucosyllactose for the prevention and treatment of coronavirus-induced inflammation

6. 11274325 - Sialyltransferases and uses thereof

7. 11236376 - Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides

8. 11046984 - Alpha (1,2) fucosyltransferase syngenes for use in the production of fucosylated oligosaccharides

9. 11028419 - Biosynthesis of human milk oligosaccharides in engineered bacteria

10. 10815511 - Biosynthesis of human milk oligosaccharides in engineered bacteria

11. 10487346 - Biosynthesis of human milk oligosaccharides in engineered bacteria

12. 10415069 - Microorganisms and methods for producing sialylated and N-acetylglucosamine-containing oligosaccharides

13. 10286001 - Use of purified 2'-fucosyllactose, 3-fucosyllactose and lactodifucotetraose as prebiotics

14. 10273516 - Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides

15. 9970018 - Biosynthesis of human milk oligosaccharides in engineered bacteria